Research archive
Research published in 2004
10 publications from 2004, newest first.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
Titles appear as published. A listing is not an endorsement, and a single study rarely settles a question. Not medically reviewed. Educational information, not medical advice.
- Case reportArch Dermatol2004 DecAntiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma.Coras B, et al.
- StudyCancer2004 Nov 15Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma.Reichle A, et al.
- StudyInt J Clin Pharmacol Ther2004 NovMetronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.Stölting S, et al.
- Clinical trialBiomed Pharmacother2004 OctOral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC).Nicolini A, et al.
- StudyAnn Oncol2004 OctMetronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity.Rozados VR, et al.
- ReviewAPMIS2004 Jul-AugEndogenous angiogenesis inhibitors.Folkman J
- StudyPhotochem Photobiol2004 Jul-AugMetronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors.Bisland SK, et al.
- StudyAnticancer Res2004 May-JunAntiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.Drevs J, et al.
- StudyAPMIS2004 MarAntiangiogenic effect of metronomic paclitaxel treatment in prostate cancer and non-tumor tissue in the same animals: a quantitative study.Lennernäs B, et al.
- ReviewCancer Treat Res2004Anti-angiogenic chemotherapy in central nervous system tumors.Kieran MW